The urge for an AIDS vaccine: perspectives from a developing country.

Abstract:

:AIDS is inexorably involving all parts of the country and all strata of society, with 10% of the urban and 3% of the rural population infected with HIV. It is increasingly a disease of women and children. The major cofactors for transmission are also sexually transmitted. For most developing countries, in spite of all education efforts, the "silent epidemic" of AIDS continues. AIDS is known but not understood; counselling modifies behavior in only 10-20% of at-risk persons. Under optimal conditions, HIV discordant females have seroconversion rates of 4.7% per year and pregnancy rates of 10.4% per year. The recent political unrest in Zaire and Haiti will further enhance the spread of AIDS in these countries. Despite these difficult periods, the work can and must continue. After all, during our 10th year of collaboration with a Haitian private research group, the Haitian government and Cornell University, Haiti has known seven different political rulers. Finally, I want to make a pledge on behalf of the millions of people who face a certain death from HIV infection and AIDS and who will never make the front page of any newspaper. For these people, you can make a difference. You must give us the tools to carry on this fight. The clinical trials must be done where they are most needed: the developing countries. Vaccines represent the only viable alternative despite the recognized obstacles of viral heterogeneity, immunogenicity, and delivery.

authors

Pape JW,Deschamps MM,Verdier RI,Jean S,Desvarieux M,Taverne G,Gelin C,Hyppolite PR,Denize J,Mellon R

doi

10.1089/aid.1992.8.1535

keywords:

["Acquired Immunodeficiency Syndrome--prevention and control","Americas","Caribbean","Delivery Of Health Care","Developing Countries","Diseases","Economic Factors","Epidemics","Haiti","Health","Health Services","Hiv Infections","Immunization","Latin America","Medicine","Needs","North America","Preventive Medicine","Primary Health Care","Vaccination","Vaccines","Viral Diseases"]

subject

Has Abstract,Author List Incomplete

pub_date

1992-08-01 00:00:00

pages

1535-7

issue

8

eissn

0889-2229

issn

1931-8405

journal_volume

8

pub_type

杂志文章
  • Correlation of Antibody Responses to a Peptide Antigen gp120-C5501-512/gp41732-744 with HIV Disease Progression.

    abstract::Antibodies to the carboxy-terminal constant (C5) region 5 of the HIV-1 envelope glycoprotein gp120 have previously been associated with slow disease progression. This is one of the regions on gp120 that interact with the transmembrane glycoprotein, gp41, anchoring it to the viral and infected cell membrane. This study...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2016.0184

    authors: Sørensen B,Sommerfelt MA,Stjernholm G,Smith PL,Ökvist M,Hovden AO,Hoddevik G,Redfield R,Ustina V,Jelmert Ø,Zeldis J,Dalgleish A

    更新日期:2017-06-01 00:00:00

  • Molecular characterization of unique intersubtype HIV type 1 A1/C recombinant strain circulating in Pune, India.

    abstract::An increasing number of circulating recombinant forms (CRFs) and unique recombinant forms (URFs) all over the world has necessitated being vigilant about new recombinants. Since the first report of a recombinant virus with an A1/C mosaic in 1998 more and more B/C and A/C recombinant viruses are being reported from Ind...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2013.0150

    authors: Pandey S,Tripathy S,Paranjape R

    更新日期:2013-09-01 00:00:00

  • Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease.

    abstract::The gag-homologous region of the human endogenous retrovirus K10 (HERV-K10) was amplified by PCR from human genomic DNA and was analyzed by DNA cloning, sequencing, and expression of open reading frames in the prokaryotic pATH expression system. The analysis of genomic DNA of three donors provided evidence that HERV-K...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1993.9.343

    authors: Mueller-Lantzsch N,Sauter M,Weiskircher A,Kramer K,Best B,Buck M,Grässer F

    更新日期:1993-04-01 00:00:00

  • Regression of feline immunodeficiency virus infection.

    abstract::Regression of feline immunodeficiency virus (FIV) infection was observed in seven of nine vertically infected kittens born to two chronically infected mother cats. Both provirus and nonmaternal FIV antibody were detected in all kittens by 4 weeks of age but only three of the seven kittens were positive by blood mononu...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1997.13.713

    authors: O'Neil LL,Burkhard MJ,Obert LA,Hoover EA

    更新日期:1997-05-20 00:00:00

  • Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.

    abstract::Infection with drug-resistant human immunodeficiency virus type 1 (HIV-1) has been documented in all countries that have surveyed for it and may result in an unfavorable response to therapy. The prevalence and characteristics of individuals with transmitted resistance to antiretroviral drugs have been scarcely describ...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2009.0012

    authors: Sprinz E,Netto EM,Patelli M,Lima JS,Furtado JJ,da Eira M,Zajdenverg R,Madruga JV,Lewi DS,Machado AA,Pedro RJ,Soares MA

    更新日期:2009-09-01 00:00:00

  • Eradication therapies for HIV Infection: time to begin again.

    abstract::Despite the success of antiretroviral therapy (ART) in decreasing mortality for HIV-1-infected patients, ART has not cured the disease. A persistent viral reservoir in the T cells of HIV patients receiving potent ART is a significant barrier preventing eradication of HIV infection. We will briefly review what is known...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章,评审

    doi:10.1089/AID.2011.0017

    authors: Margolis DM

    更新日期:2011-04-01 00:00:00

  • Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.

    abstract::We have previously shown that the cell line 6D5(451) chronically infected with the HIV-1 isolate HTLV-III(451), secretes the HIV-1 envelope glycoproteins gp120 and gp160 in the extracellular medium. The HTLV-III(451) gp120 and gp160 were purified by sequential affinity chromatographic steps using a monoclonal antibody...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1990.6.371

    authors: Kalyanaraman VS,Rodriguez V,Veronese F,Rahman R,Lusso P,DeVico AL,Copeland T,Oroszlan S,Gallo RC,Sarngadharan MG

    更新日期:1990-03-01 00:00:00

  • The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort.

    abstract::Antigenic properties of the V3 region are reflected by HIV-1 serotypes. These may represent biological properties of the virus. We serotyped HIV-1 in 142 serum samples from participants in a rural Uganda cohort who seroconverted between August 1991 and December 2001. Clinical progression was assessed using Cox proport...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2004.20.932

    authors: Senkaali D,Muwonge R,Morgan D,Yirrell D,Whitworth J,Kaleebu P

    更新日期:2004-09-01 00:00:00

  • The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants.

    abstract::Both saponin and muramyl dipeptide (MDP) formulated with a squalane-in-water emulsion of large particle size prepared with a vortex mixer were superior to Al(OH)3 as adjuvants for HIV gp120 in mice. All the adjuvants induced IgG1 antibody, but saponin elicited the highest titers of IgG2a. The secretion of interleukin-...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1992.8.1765

    authors: Bomford R,Stapleton M,Winsor S,McKnight A,Andronova T

    更新日期:1992-10-01 00:00:00

  • HIV non-B subtype distribution: emerging trends and risk factors for imported and local infections newly diagnosed in South Australia.

    abstract::Monitoring HIV subtype distribution is important for understanding transmission dynamics. Subtype B has historically been dominant in Australia, but in recent years new clades have appeared. Since 2000, clade data have been collected as part of HIV surveillance in South Australia. The aim of this study was to evaluate...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2012.0082

    authors: Hawke KG,Waddell RG,Gordon DL,Ratcliff RM,Ward PR,Kaldor JM

    更新日期:2013-02-01 00:00:00

  • Temporal lobe electroencephalogram power modifications during olfactory stimulation in HIV-infected patients.

    abstract::Evidence derived from studies concerning brain metabolism and brain electrical activity suggests that temporal lobe functioning is impaired in the course of HIV infection. To test the hypothesis of temporal lobe dysfunction in HIV infection, we utilized computerized electroencephalogram (EEG) analysis to evaluate temp...

    journal_title:AIDS research and human retroviruses

    pub_type: 临床试验,杂志文章

    doi:10.1089/aid.1996.12.547

    authors: Grassi B,Locatelli M,Lazzarin A,Scarone S

    更新日期:1996-04-10 00:00:00

  • In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication.

    abstract::Monoclonal antibodies (mAbs) specific for CD4 are potent inhibitors of HIV replication in vitro. These agents may be useful prophylactically or in chronic HIV infection if they can be administered without inducing immunosuppression. In the present study, we explored the safety of a CD4-specific murine mAb in rhesus mo...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1993.9.199

    authors: Reimann KA,Burkly LC,Burrus B,Waite BC,Lord CI,Letvin NL

    更新日期:1993-03-01 00:00:00

  • Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.

    abstract::In recent years, increasing numbers of patients infected with HIV-1 non-B subtypes have been treated with modern antiretroviral regimens. Therefore, a better knowledge of HIV drug resistance in non-B strains is crucial. Thus, we compared the mutational pathways involved in drug resistance among the most common non-B s...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2011.0142

    authors: Santoro MM,Alteri C,Ronga L,Flandre P,Fabeni L,Mercurio F,D'Arrigo R,Gori C,Palamara G,Bertoli A,Forbici F,Salpini R,Boumis E,Tozzi V,Visco-Comandini U,Zaccarelli M,Van Houtte M,Pattery T,Narciso P,Antinori A,Cecc

    更新日期:2012-10-01 00:00:00

  • Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients.

    abstract::Population genotyping (PG) can underestimate resistance if resistance-containing low abundance variants go undetected. PG and clonal analysis (CA) results were compared in virologic failures (VFs) from a 48-week clinical trial that evaluated once-daily fosamprenavir/ritonavir (FPV/r) 1400 mg/100 mg or atazanavir/riton...

    journal_title:AIDS research and human retroviruses

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1089/aid.2009.0189

    authors: Ross LL,Weinberg WG,DeJesus E,Fischl MA,Horton JH,Pappa KA,Lancaster CT,Pakes GE,Smith KY

    更新日期:2010-04-01 00:00:00

  • Conference summary: novel HIV therapies--from discovery to clinical proof of concept.

    abstract::In this report we have highlighted only a few examples of the extensive efforts underway to better understand the process of HIV pathogenesis, to develop new therapeutic agents to inhibit virus replication, and to identify strategies to restore damage done to the immune system during HIV disease progression. It is exp...

    journal_title:AIDS research and human retroviruses

    pub_type:

    doi:10.1089/aid.1996.12.859

    authors: Miller RH,Turk SR,Black RJ,Bridges S,Sarver N

    更新日期:1996-07-01 00:00:00

  • Prevalence and Risk Factors for Human Immunodeficiency Virus Infection Among Female Sex Workers: Distinct Offers of Sexual Services in a Municipality of the Brazilian Amazon.

    abstract::This study determined the prevalence of human immunodeficiency virus (HIV) infection and its associated factors in female sex workers (FSWs) from the municipality of Bragança in the state of Pará, Brazil. A cross-sectional study using a respondent-driven sampling method was used to investigate 137 FSWs. They were inte...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2019.0032

    authors: da Costa LM,Raiol NC,Lisboa BLA,Frade PCR,Blandtt LDS,Silva-Oliveira GC,Machado LFA,Martins LC,Oliveira-Filho AB

    更新日期:2019-09-01 00:00:00

  • IL-12/GM-CSF coadministration in an SIV DNA prime/protein boost protocol enhances Gag-specific T cells but not virus-specific neutralizing antibodies in rhesus macaques.

    abstract::Coadministration of pVecB7, a replication-defective SIV DNA vaccine, with interleukin-12 and GM-CSF expression plasmids, induced markedly enhanced control of viral replication and disease-free survival in macaques challenged intrarectally with pathogenic SIVsmE660. Protective mechanisms correlated with broader cell-me...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/088922203322493058

    authors: O'Neill E,Bostik V,Montefiori DC,Kraiselburd E,Villinger F

    更新日期:2003-10-01 00:00:00

  • The maximal tolerable intravenous dosage of pentoxifylline in AIDS patients does not inhibit lipopolysaccharide-stimulated tumor necrosis factor alpha production.

    abstract::Tumor necrosis factor alpha (TNF-alpha) may be involved in the pathogenesis of metabolic and endocrine changes in HIV infection. Pentoxifylline (PTX) is able to suppress the production of TNF-alpha in vitro. The effect of two dosages of intravenously administered PTX on clinical symptoms and ex vivo LPS-stimulated TNF...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1998.14.299

    authors: Heijligenberg R,Romijn JA,Ackermans M,Endert E,Timmer JG,Sauerwein HP

    更新日期:1998-03-01 00:00:00

  • Postvaccination C-Reactive Protein and C5/gp41732-744 Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x.

    abstract::Therapeutic vaccination has the potential to contribute to functional HIV cure strategies. However, to show functional HIV cure, study participants must be taken off combination antiretroviral therapy (cART). The availability of suitable biomarkers that can predict viral load (VL) or CD4 count outcomes following thera...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/AID.2017.0179

    authors: Huang Y,Zhang L,Jolliffe D,Sanchez B,Stjernholm G,Jelmert Ø,Ökvist M,Sommerfelt MA

    更新日期:2018-03-01 00:00:00

  • Immunization with recombinant gp160 prolongs the survival of HIV-1 transgenic mice.

    abstract::A strain of mouse transgenic for the env gene of the HIV-1 virus was used to study the immunogenicity of a gp160-derived vaccine (the protein encoded by the HIV env gene) and its effect on disease progression. Untreated transgenic mice frequently developed a rapidly progressive renal disease similar to that affecting ...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1993.9.979

    authors: Shirai A,Klinman DM

    更新日期:1993-10-01 00:00:00

  • Membrane-interactive phospholipids inhibit HIV type 1-induced cell fusion and surface gp160/gp120 binding to monoclonal antibody.

    abstract::Membrane-interactive phospholipids (PLs), previously evaluated for activity against HIV-1 in vitro, are known to affect late steps in viral replication. Studies were done to determine the effects of PL analogs on post-translational processing of HIV-1 proteins, binding of viral surface gp160/gp120 to CD4 receptor, and...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1995.11.705

    authors: Krugner-Higby L,Goff D,Edwards T,Iyer N,Neufeld J,Kute T,Morris-Natschke S,Ishaq K,Piantadosi C,Kucera LS

    更新日期:1995-06-01 00:00:00

  • Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?

    abstract::Perinatal antiretroviral (ARV) exposure has been related to hyperlactatemia and lactic acidosis in infants born to HIV-infected mothers. Our objective was to determine the incidence of these conditions during the first year of life in uninfected infants born to HIV-infected mothers and compare the data with infants bo...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2011.0198

    authors: Soler-Palacín P,Martín-Nalda A,Martínez-Gómez X,Melendo S,Riudor E,Arranz JA,Espiau M,Figueras C

    更新日期:2012-08-01 00:00:00

  • Evaluation of primary resistance to HIV entry inhibitors among brazilian patients failing reverse transcriptase/protease inhibitors treatment reveal high prevalence of maraviroc resistance-related mutations.

    abstract::Entry inhibitor is a new class of drugs that target the viral envelope protein. This region is variable; hence resistance to these drugs may be present before treatment. The aim of this study was to analyze the frequency of patients failing treatment with transcriptase reverse and protease inhibitors that would respon...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2010.0057

    authors: Alencar CS,Nishiya AS,Ferreira S,Giret MT,Diaz RS,Sabino EC

    更新日期:2010-12-01 00:00:00

  • Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS.

    abstract::With improved survival and aging, more persons living with HIV/AIDS (PLWHA) are at risk for colorectal cancer (CRC). This retrospective longitudinal study evaluated patient characteristics associated with CRC screening in our HIV cohort. Patients were followed beginning at age 50 years during a study period from Janua...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2014.0256

    authors: Burkholder GA,Tamhane AR,Appell LE,Willig JH,Saag MS,Raper JL,Westfall AO,Mugavero MJ

    更新日期:2015-05-01 00:00:00

  • Short communication: dynamic constraints on the second phase compartment of HIV-infected cells.

    abstract::The cells responsible for the second phase decay of HIV-1 viremia following the initiation of antiretroviral therapy have yet to be identified. A dynamic model that considers where drugs act in the virus life cycle places constraints on candidate cell types. In this regard, the rapid drop in viremia in patients starti...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/AID.2010.0199

    authors: Spivak AM,Rabi SA,McMahon MA,Shan L,Sedaghat AR,Wilke CO,Siliciano RF

    更新日期:2011-07-01 00:00:00

  • Near full-length genomic characterization of a novel HIV type 1 subtype B/C recombinant strain from Yunnan, China.

    abstract::Recombination contributes substantially to the genetic diversity of HIV-1, and mosaic strains arise frequently, especially in populations in which multiple subtypes circulate. Yunnan, which borders the "Golden triangle" region of Southeast Asia in the south, was considered as the epicenter of China. B, CRF01_AE, CRF07...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2010.0001

    authors: Li L,Chen L,Yang S,Liu Y,Li H,Bao Z,Wang Z,Zhuang D,Liu S,Li J

    更新日期:2010-06-01 00:00:00

  • Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development.

    abstract::The gene encoding the major envelope glycoprotein of the HIV-SF2 isolate was engineered for the secretion of recombinant gp120 (rgp120SF2) from permanent Chinese hamster ovary (CHO) cell lines. Cellular production methods were scaled up and a method for purification of the secreted glycoprotein was devised. Mild purif...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1993.9.1233

    authors: Scandella CJ,Kilpatrick J,Lidster W,Parker C,Moore JP,Moore GK,Mann KA,Brown P,Coates S,Chapman B

    更新日期:1993-12-01 00:00:00

  • HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea.

    abstract::In this study, HIV strains circulating among military personnel were characterized, in Malabo, the capital city of Equatorial Guinea. One sample was found to be HIV-2 group A while a high degree of genetic diversity was recorded in the pol region of 41 HIV-1-positive samples. CRF02_AG accounted for 53.7% of the strain...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.2010.0046

    authors: Djoko CF,Wolfe ND,Vidal N,Tamoufe U,Montavon C,LeBreton M,Pike BL,Fair J,Mbacham WF,Benito A,Rimoin AW,Saylors K,Mpoudi-Ngole E,Grillo MP,Peeters M

    更新日期:2010-09-01 00:00:00

  • Gene for chinese rhesus macaque DC-SIGN predicts the existence of A but not B isoforms of the protein.

    abstract::We report here the gene for DC-SIGN from Chinese rhesus macaques. DC-SIGN is a C-type lectin expressed by dendritic cells (DCs). It is involved in the interaction of DCs with T cells, and in transmission to T cells of HIV-1 and SIV. Alternative splicing in human DC-SIGN yields A and B isoforms of the protein. The over...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/088922202760265641

    authors: Santos PR,Petitprez K,Butor C

    更新日期:2002-09-01 00:00:00

  • An interactive Web site providing major histocompatibility ligand predictions: application to HIV research.

    abstract::EpiMatrix/HIV, a tool that is currently available on the World Wide Web, enables researchers to screen HIV proteins for potential MHC ligands. We have performed a comparison of EpiMatrix predictions to 158 published allotype-specific HLA-associated peptides (MHC ligands) derived from 133 proteins. The top 10 ranked Ep...

    journal_title:AIDS research and human retroviruses

    pub_type: 杂志文章

    doi:10.1089/aid.1997.13.529

    authors: De Groot AS,Jesdale BM,Szu E,Schafer JR,Chicz RM,Deocampo G

    更新日期:1997-05-01 00:00:00